Ticker	Volume	Price	Price Delta
DJIA	15,407.70	+72.38	0.47%
S&P 500	1,671.81	+5.52	0.33%
Nasdaq	3,507.70	+11.27	0.32%

Ticker

Volume

Price

Price Delta

DJIA

15,407.70

+72.38

0.47%

S&P 500

1,671.81

+5.52

0.33%

Nasdaq

3,507.70

+11.27

0.32%

Ticker	Volume	Price	Price Delta
STOXX 50	2,821.65	-2.85	-0.10%
FTSE 100	6,803.87	+48.24	0.71%
DAX	8,472.20	+16.37	0.19%

Ticker

Volume

Price

Price Delta

STOXX 50

2,821.65

-2.85

-0.10%

FTSE 100

6,803.87

+48.24

0.71%

DAX

8,472.20

+16.37

0.19%

Ticker	Volume	Price	Price Delta
Nikkei	15,381.00	+20.21	0.13%
Hang Seng	23,366.40	-126.66	-0.54%
S&P/ASX 200	5,180.06	-28.98	-0.56%

Ticker

Volume

Price

Price Delta

Nikkei

15,381.00

+20.21

0.13%

Hang Seng

23,366.40

-126.66

-0.54%

S&P/ASX 200

5,180.06

-28.98

-0.56%

WATCH LIVE

Tim Cook at the Apple Tax Hearings

Medigus Surges Most in Four Months on FDA Approval Request

By Shoshanna Solomon - 2012-01-25T09:01:06Z

Medigus Ltd. (MDGS) surged the most in more than four months after the company said it will seek U.S. Food and Drug Administration approval to market its SRS device for the treatment of gastro-esophageal reflux disease.

Shares of the maker of endoscopic procedures and devices rallied 16 percent, the most since Sept. 11, to 0.698 shekel at 10:38 a.m. in Tel Aviv.

To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at ssolomon22@bloomberg.net

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net

Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.